Toshiya Moriwaki

579 total citations
26 papers, 500 citations indexed

About

Toshiya Moriwaki is a scholar working on Oncology, Pharmacology and Pharmacology. According to data from OpenAlex, Toshiya Moriwaki has authored 26 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pharmacology and 7 papers in Pharmacology. Recurrent topics in Toshiya Moriwaki's work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Toshiya Moriwaki is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Toshiya Moriwaki collaborates with scholars based in Japan, Germany and United Kingdom. Toshiya Moriwaki's co-authors include Hideki Hirabayashi, Yukihiro Ikeda, Nobuyuki Amano, Takashi Kojima, Shunichirou Tsutsumi, Hiroshi Sugimoto, Katsuhiko Yamamoto, Shin-ichi Matsumoto, Satoru Asahi and Akio Morohashi and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Toshiya Moriwaki

26 papers receiving 481 citations

Peers

Countries citing papers authored by Toshiya Moriwaki

Since Specialization

Citations

This map shows the geographic impact of Toshiya Moriwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiya Moriwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiya Moriwaki more than expected).

Fields of papers citing papers by Toshiya Moriwaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiya Moriwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiya Moriwaki. The network helps show where Toshiya Moriwaki may publish in the future.

Co-authorship network of co-authors of Toshiya Moriwaki

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiya Moriwaki. A scholar is included among the top collaborators of Toshiya Moriwaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiya Moriwaki. Toshiya Moriwaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanistic Multilayer Quantitative Model for Nonlinear Pharmacokinetics, Target Occupancy and Pharmacodynamics (PK/TO/PD) Relationship of D-Amino Acid Oxidase Inhibitor, TAK-831 in Mice 2020 ·Pharmaceutical Research ·Tomoki Yoneyama, Sho Sato, (unknown), Rosa Fradley, (unknown), (unknown), (unknown), Toshal R. Patel, Yoshihiko Tagawa, Toshiya Moriwaki, Satoru Asahi	7
2	Impact of P-Glycoprotein on Intestinal Absorption of an Inhibitor of Apoptosis Protein Antagonist in Rats: Mechanisms of Nonlinear Pharmacokinetics and Food Effects 2018 ·Pharmaceutical Research ·S. Yamamoto, Yohei Kosugi, Hideki Hirabayashi, Toshiya Moriwaki	7
3	Influence of body composition on disposition of the highly fat distributed compound as analysed by physiologically based pharmacokinetic (PBPK) modeling and simulation 2017 ·Biopharmaceutics & Drug Disposition ·Akihiko Goto, Yoshihiko Tagawa, (unknown), Sho Sato, M. Yamamoto, Takeshi Wakabayashi, Tetsuya Tsukamoto, Joost DeJongh, Tamara J. van Steeg, Toshiya Moriwaki, Satoru Asahi	1
4	Impact of acute fat mobilisation on the pharmacokinetics of the highly fat distributed compound TAK‐357, investigated by physiologically based pharmacokinetic (PBPK) modeling and simulation 2017 ·Biopharmaceutics & Drug Disposition ·Akihiko Goto, Yoshihiko Tagawa, (unknown), Sho Sato, Yoshiyuki Furukawa, Takeshi Wakabayashi, Tetsuya Tsukamoto, Joost DeJongh, Tamara J. van Steeg, Toshiya Moriwaki, Satoru Asahi	2
5	Risk assessment of drug–drug interactions using hepatocytes suspended in serum during the drug discovery process 2013 ·Xenobiotica ·Yohei Kosugi, Hideki Hirabayashi, (unknown), Yasushi Fujioka, Teruaki Okuda, Toshiya Moriwaki	5
6	Retrospective Analysis of P-Glycoprotein–Mediated Drug-Drug Interactions at the Blood-Brain Barrier in Humans 2013 ·Drug Metabolism and Disposition ·Hiroshi Sugimoto, Hideki Hirabayashi, Nobuyuki Amano, Toshiya Moriwaki	16
7	Tetrahydro-naphthols as orally available TRPV1 inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Klaus Urbahns, Takeshi Yura, (unknown), Masaomi Tajimi, Hiroshi Fujishima, Tsutomu Masuda, Noriyuki Yamamoto, (unknown), (unknown), (unknown), (unknown), Toshiya Moriwaki, David J. Madge, Fiona Chan, Muneto Mogi	5
8	Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties 2011 ·International Journal of Pharmaceutics ·Shunichirou Tsutsumi, (unknown), (unknown), Takashi Kojima, Yukihiro Ikeda, Toshiya Moriwaki, Kenjirou Higashi, Kunikazu Moribe, Keiji Yamamoto	58
9	In Vivo Biliary Clearance Should Be Predicted by Intrinsic Biliary Clearance in Sandwich-Cultured Hepatocytes 2011 ·Drug Metabolism and Disposition ·Masanori Nakakariya, Midori Ono, Nobuyuki Amano, Toshiya Moriwaki, Kazuya Maeda, Yuichi Sugiyama	29
10	Development of a quantification method for digoxin, a typical P-glycoprotein probe in clinical and non-clinical studies, using high performance liquid chromatography–tandem mass spectrometry: The usefulness of negative ionization mode to avoid competitive adduct-ion formation 2011 ·Journal of Chromatography B ·Hideki Hirabayashi, Hiroshi Sugimoto, Shin-ichi Matsumoto, Nobuyuki Amano, Toshiya Moriwaki	23
11	Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence 2011 ·Bioorganic & Medicinal Chemistry Letters ·Klaus Urbahns, Takeshi Yura, Muneto Mogi, Masaomi Tajimi, Hiroshi Fujishima, Tsutomu Masuda, (unknown), Toshiya Moriwaki, Timothy B. Lowinger, Heinrich Meier, Fiona Chan, David J. Madge, (unknown)	8
12	Establishment of In Vitro P-Glycoprotein Inhibition Assay and Its Exclusion Criteria to Assess the Risk Of Drug–Drug Interaction at the Drug Discovery Stage 2011 ·Journal of Pharmaceutical Sciences ·Hiroshi Sugimoto, Shin-ichi Matsumoto, (unknown), Shin‐Ichi Niwa, Hideki Hirabayashi, Nobuyuki Amano, Toshiya Moriwaki	35
13	High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate 2010 ·International Journal of Pharmaceutics ·Takashi Kojima, Shunichirou Tsutsumi, Katsuhiko Yamamoto, Yukihiro Ikeda, Toshiya Moriwaki	95
14	A 96-Well Plate Assay for CYP4503A Induction Using Cryopreserved Human Hepatocytes 2010 ·Drug Metabolism and Disposition ·(unknown), (unknown), Teruaki Okuda, Toshiya Moriwaki	14
15	Quantitative Investigation of the Impact of P-Glycoprotein Inhibition on Drug Transport across Blood-Brain Barrier in Rats 2010 ·Drug Metabolism and Disposition ·Hiroshi Sugimoto, Hideki Hirabayashi, (unknown), (unknown), Nobuyuki Amano, Toshiya Moriwaki	46
16	High Throughput Screening of Pharmacokinetics and Metabolism in Drug Discovery (II) —Investigation on <i>In vitro</i> and <i>In vivo</i> Correlation in Drug Metabolism Screening— 2005 ·YAKUGAKU ZASSHI ·Hiroshi Komura, Ken‐ichi Matsuda, (unknown), (unknown), (unknown), Yoko Murayama, Toshiya Moriwaki, (unknown)	2
17	Pharmacokinetic Analysis of Ramatroban Using a Recirculatory Model with Enterohepatic Circulation by Measuring Portal and Systemic Blood Concentration Difference in Sprague-Dawley and Eisai Hyperbilirubinemic Rats 2004 ·Pharmaceutical Research ·Toshiya Moriwaki, Hiroyuki Yasui, Akira Yamamoto	4
18	A Recirculatory Model with Enterohepatic Circulation by Measuring Portal and Systemic Blood Concentration Difference 2003 ·Journal of Pharmacokinetics and Pharmacodynamics ·Toshiya Moriwaki, Hiroyuki Yasui, Akira Yamamoto	14
19	A Recirculatory Model for Local Absorption and Disposition of Ciprofloxacin by Measuring Portal and Systemic Blood Concentration Difference 2002 ·Journal of Pharmaceutical Sciences ·Toshiya Moriwaki, Hiroyuki Yasui, (unknown), (unknown)	8
20	DDS with MFGM(milk fat globule membrane): preparation of fat emulsions and emulsifiability of MFGM. 1990 ·Drug Delivery System ·Toshiya Moriwaki, Hiroshi Yoshikawa, Kanji Takada, Shozo Muranishi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact